Voluntary Recall Information

Philips Respironics Sleep and Respiratory Care devices


In June 2021, after discovering a potential health risk related to the foam in certain CPAP, BiPAP and Mechanical Ventilator devices, Philips Respironics issued a voluntary Field Safety Notice (outside U.S.) / voluntary recall notification (U.S. only).

News and updates    

An update on our progress 


Globally, we have remediated 99% of actionable* sleep therapy device registrations to date. 

As the remediation of the ventilator devices continues, Philips Respironics will be communicating with Durable Medical Equipment providers (DMEs) directly throughout the process. If you are a patient or caregiver with an affected Philips Respironics ventilation device, you do not need to take any action. All ventilation remediation will be handled via your DME.

*Actionable registrations are those that contain the necessary information needed to complete the remediation and are not awaiting further information.

Explained: The voluntary Philips Respironics sleep and respiratory care devices recall*


* This is a voluntary recall notification in the US and field safety notice in other countries

Explained: The Philips Respironics Consent Decree

April 4, 2024

You are about to visit a Philips global content page


You are about to visit a Philips global content page


Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.